LumiraDx, a next-generation point of care diagnostics company will be hosting an industry workshop at this week’s American Association for Clinical Chemistry (AACC) Annual Conference in Chicago. The workshop, held on July 27th, will include data-backed insights on the impact of LumiraDx’s advanced microfluidic technology over lateral flow point-of-care antigen tests, and the role of these rapid immunoassays in response to the COVID-19 pandemic.
Cytovale®, a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-mediated diseases, will reveal its 510(k) pending Cytovale system and 10-minute IntelliSep® sepsis risk stratification test at the American Association for Clinical Chemistry (AACC) annual meeting, where new data featuring the test will also be shared. The instrument can be seen in the Cytovale booth, no. 5045, in the exhibit hall during Clinical Lab Expo hours. The IntelliSep test was recently named an AACC Disruptive Technology Award Semifinalist and is also being featured in the Disruptive Tech area of the exhibit hall during the meeting.
BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, today announced the launch of its digital Connected Diagnostics Platform at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo. This comprehensive, end-to-end platform is a one-stop shop for in vitro diagnostics manufacturers that streamlines workflows, accelerates revenue growth and drives innovation.
Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex workflows for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs liberates genomics to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy for detection and surveillance of infectious diseases. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow’s novel pathogens.
At the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.
Rhinostics introduces another breakthrough in automated sample collection technologies with the launch of the patent-pending VERIstic™ Collection Device focused on small volume blood collection.
DiaSorin (FTSE MIB: DIA) announced today the FDA 510(k) clearance and the commercial launch in the US of the host-protein signature-based assay LIAISON® MeMed BV®
OMNIgene®•GUT DNA and RNA product (OMR-205) is now available to gut microbiome researchers. The product allows for self-collection, stabilization, storage and transportation of both microbial DNA and RNA at ambient temperature for gut microbiome profiling.
Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry, is proud to announce the release of their second-generation solution for Human Fecal Trichrome (HFT) for human parasites.
A study authored by researchers at Quest Diagnostics and presented at ASM Microbe on June 9-12th 2022 in Washington, D.C. provides evidence that the Techcyte technology aids in the detection of intestinal protozoa.
Specifically designed to support the Sysmex® XN-Series hematology line, AutoSorter™ XN is a robust robotic platform for pre- and post- analytic specimen processing in demanding laboratory environments.
AutoSorter™ 1200 is Yaskawa Motoman’s high-speed sorting instrument for pre- and post-analytic specimen processing. It can process up to 1,200 tubes/hr. A large sort deck area yields extended walkaway times and expanded deck configuration options, while its reduced footprint saves lab floorspace.
KT-8000 is equipped with auto-loader and sample mixer. This brand new fully automated hematology analyzer can free your hands and extend walk-away time. Smart counting mode can fit into more application scenarios than other hematology analyzers. Support both open vial/auto loading mode, and emergency sample first, and fit all the demands. Powerful data management unit has improved the work efficiency markedly.
Messe Düsseldorf will participate in the AACC Clinical Lab Expo 2022 in order to promote its “MEDICAlliance” program of regional and international medical trade fairs organized around the globe.
The planning for the world’s leading medical trade fair MEDICA 2022 as well as for COMPAMED 2022, the No. 1 trade fair for suppliers of the medical technology industry, has entered the next stage. The current number of exhibitor registrations indicates that participation will surpass last year’s results (MEDICA 2021: 3,033; COMPAMED 2021: 490). Exhibitors can still register online for all segments at www.medica.de/2330 and www.compamed.de/2330 MEDICA and COMPAMED will take place concurrently from November 14 – 17, 2022 at the fairgrounds in Düsseldorf, Germany.